← All stocks

BALCHEM CORP

BCPC Net selling
CIK 0000009326 #1260 in the set updated 21 Sep 2026
Bought (120 mo)
$312.14K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$39.52M
$0.00 on a plan · $25.16M straight out of an exercise
Sold at will
$14.37M
26 of 55 sales
Net
−$39.21M
−$14.05M against sales at will

By person

29 insiders · 57 transactions
11.7×

Ted Harris holds 11.7 times base salary in stock. $14.05M of shares against $1.20M in salary for 2025.

Salary from the company's own proxy. The shares are what Ted Harris last reported holding, valued at $153.80, the price Common Stock was last bought or sold at on the open market here, on 4 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Backus William A.
VP & Chief Accounting Officer
$14.00M (15) scheduled
−$14.00M
6,868
0.0215%
$1.06M
−61.8%
Harris Theodore L
Chairman, President & CEO
$9.86M (7) scheduled
−$9.86M
91,373
0.2866%
$14.05M
+127.8%
ROSSI DINO A
Retired Director
$4.05M (7)
−$4.05M
25,068
0.0786%
$3.86M
−66.7%
van Gunsteren Job Leonard
SVP and GM, Specialty Products
$3.41M (8) scheduled
−$3.41M
10,149
0.0318%
$1.56M
+25.4%
Fischer David B
Director
$2.88M (6)
−$2.88M
8,859
0.0278%
$1.36M
−41.4%
Sestrick Michael Robert
SVP & Chief Technology Officer
$2.30M (3) scheduled
−$2.30M
4,762
0.0149%
$732.41K
−14.9%
LUDWIG DAVID F
Vice President
$1.15M (2) scheduled
−$1.15M
36,685
0.1151%
$5.64M
−27.4%
Tignor Michael Brent
SVP & Chief HR Officer
$840.99K (2) scheduled
−$840.99K
10,723
0.0336%
$1.65M
+93.0%
MCMILLAN EDWARD
Director
$339.05K (2)
−$339.05K
24,495
0.0768%
$3.77M
−14.2%
Wineinger Matthew David
Director
$209.13K (1)
−$209.13K
8,012
0.0251%
$1.23M
+343.1%
Reid Martin Luther
SVP Chief Supply Chain Officer
$185.33K (1)
−$185.33K
9,073
0.0285%
$1.40M
+186.2%
Knutson Daniel E
Director
$57.92K (1)
+$57.92K
6,899
0.0216%
$1.06M
MASON SCOTT C
Vice President
$254.22K (1)
$309.00K (1)
−$54.78K
9,675
0.0304%
$1.49M
+9.9%
FITZPATRICK FRANK
Vice President
68,726
0.2156%
$10.57M
−1.9%
Premdas Perry W
Director
51,008
0.1600%
$7.85M
+11.2%
TELEVANTOS JOHN Y
Director
29,078
0.0912%
$4.47M
+0.1%
Bengtsson Carl Martin
EVP & Chief Financial Officer
27,926
0.0876%
$4.30M
+132.7%
COOMBS PAUL D
Director
22,540
0.0707%
$3.47M
+16.4%
Hyde James C
Sr. Vice President
15,915
0.0499%
$2.45M
+12.8%
Griffin Jonathan Harrison
SVP & GM, Animal Nutrition
12,737
0.0400%
$1.96M
+48.0%
Boned Frederic
SVP/GM, Human Nutri. & Health
8,978
0.0282%
$1.38M
+199.3%
Miyata Hatsuki
EVP, CLO, & Secretary
8,745
0.0274%
$1.35M
+118.6%
Stach Mark A
General Counsel
7,763
0.0244%
$1.19M
+309.7%
Fish Kathleen B
Director
3,429
0.0108%
$527.39K
Graham George
SVP and Chief R&D Officer
3,200
0.0100%
$492.17K
Lee Joyce J.
Director
2,776
0.0087%
$426.96K
+370.5%
Rigaud Olivier
Director
2,390
0.0075%
$367.59K
VICENTE MONICA
Director
2,390
0.0075%
$367.59K
Coelho Mary Theresa
Chief Financial Officer
2,105
0.0066%
$323.76K
+3.6%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 240
Amendments (4/A) skipped 18
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 29
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 769,664
Sales filed before the plan box existed 11
History held since 2 Sep 2016